Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Relay Therapeutics, Inc. (RLAY) had Normalized Pre-Tax Income of $-73.29M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$3.00M |
|
$-73.29M |
|
-- |
|
$3.00M |
|
$81.59M |
|
$-78.59M |
|
$5.30M |
|
$-73.29M |
|
|
Normalized Pre-Tax Income |
$-73.29M |
$-73.29M |
|
$-73.29M |
|
$-73.29M |
|
$-73.29M |
|
$-78.59M |
|
$-78.87M |
|
179.85M |
|
179.85M |
|
$-0.41 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$658.46M |
|
$1.22M |
|
$41.15M |
|
$699.61M |
|
$29.75M |
|
-- |
|
$27.68M |
|
$57.43M |
|
$642.18M |
|
$642.18M |
|
$642.18M |
|
189.21M |
|
| Cash Flow Statement Financials | |
$-51.11M |
|
$32.90M |
|
$138.78M |
|
$85.35M |
|
$205.93M |
|
$120.57M |
|
$10.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2619.67% |
|
-2619.67% |
|
-- |
|
-2443.03% |
|
-2443.03% |
|
$-51.11M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-11.41% |
|
-11.41% |
|
-10.48% |
|
-11.41% |
|
$3.39 |
|
$-0.28 |
|
$-0.28 |
|